ClinConnect ClinConnect Logo
Search / Trial NCT06851533

Comparing Thoracolumbar Interfascial and Quadro Iliac Plane Blocks on Postoperative Opioid Use Following Lumbar Microsurgery

Launched by MEDIPOL UNIVERSITY · Feb 24, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Postoperative Pain Ultrasound Guided Nerve Block

ClinConnect Summary

This clinical trial is studying two different ways to manage pain after a common back surgery called lumbar microdiscectomy, which is often done to treat herniated discs. Researchers want to see how well two types of nerve blocks, the Thoracolumbar Interfascial Plane (TLIP) block and the Quadro Iliac Plane block, can help reduce the need for opioid pain medications after surgery. Opioids can be effective for pain relief but may cause unwanted side effects like nausea, difficulty breathing, and dependency. By comparing these two methods, the study aims to determine which one leads to less opioid use and fewer side effects.

To participate in this trial, individuals should be between the ages of 18 and 80 and scheduled for lumbar microdiscectomy surgery. They should be in good health overall, classified as ASA physical status I to III, which means they have no serious health issues. However, people with certain allergies, those who are pregnant, or anyone with significant mental health or neurological conditions cannot join the study. Participants will receive either of the two nerve blocks before their surgery and will be monitored afterward for pain levels and any side effects, helping to improve pain management practices for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 to 80 years
  • American Society of Anesthesiologists (ASA) physical status I to III
  • scheduled for lumbar microdiscectomy surgery
  • Exclusion Criteria:
  • Known allergy to local anesthetics
  • Any other significant drug allergies related to the study interventions
  • Pregnancy
  • Pre-existing psychiatric or neurological disorders
  • Inability to provide informed consent

About Medipol University

Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported